Compare Amgen, Inc. (AMGN) vs Fubotv Inc (FUBO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Fubotv Inc — how do they compare? Amgen, Inc. trades at $357.23 (market cap $196.12B), while Fubotv Inc trades at $9.94 (market cap $270.29M). The key difference: Amgen, Inc. is far larger — about 725.6× Fubotv Inc's market cap, and Amgen, Inc. pays a 2.77% dividend while Fubotv Inc pays none. Which is the better fit depends on your goals.
| AMGN | FUBO | |
|---|---|---|
Market Cap | $196.12B | $270.29M |
Sector | Health | Technology |
52-Week High | $388.16 | $54.72 |
52-Week Low | $271.18 | $8.09 |
Enterprise Value | $241.41B | $440.71M |
Dividend Yield | 2.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
FUBO stock trades at $9.18, down 3.57% on the day, amid a bearish technical signal. The company shows improving fundamentals with revenue reaching $1.62B in 2024 and a projected net income margin of 7.61% for 2025, while valuation ratios like P/E of 2.39 and P/S of 0.18 appear attractive. Recent news highlights the appointment of Alisa Bowen as CEO, bringing media industry experience.
The outlook is mixed; analyst consensus is a Buy with a $16.25 price target, but risks include persistent negative cash flows, high debt levels, and competitive pressures in streaming. Investor sentiment is cautious pending execution of the new leadership's strategy and path to sustained profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →
